Evidence map›Paper›PMID 26147574›Full record

ArticlePloS one2015

Changes in Serum Levels of Myokines and Wnt-Antagonists after an Ultramarathon Race.

Katharina Kerschan-Schindl, Markus M Thalmann, Elisabeth Weiss, Maria Tsironi, Ursula Föger-Samwald, Johann Meinhart, Katerina Skenderi, Peter Pietschmann

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Effect of Various Exercise Regimens on Selected Exercise-Induced Cytokines in Healthy People.International journal of environmental research and public health · 2021
    Review
  11. Review
  12. Review
  13. Romosozumab: a novel bone anabolic treatment option for osteoporosis?Wiener medizinische Wochenschrift (1946) · 2020
    Article
  14. Hepatokines-a novel group of exercise factors.Pflugers Archiv : European journal of physiology · 2019
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Katharina Kerschan-SchindlDepartment of Physical Medicine and Rehabilitation, Medical University of Vienna, Vienna, Austria.
Markus M ThalmannDepartment of Cardiovascular Surgery, Hospital Hietzing, Vienna, Austria.
Elisabeth WeissDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Maria TsironiSchool of Nursing, University of Peloponnese, Sparta, Greece.
Ursula Föger-SamwaldDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Johann MeinhartKarl Landsteiner Institute for Cardiovascular Surgical Research, Vienna, Austria.
Katerina SkenderiDepartment of Nutrition and Dietetics, Harokopio University, Athens, Greece.
Peter PietschmannDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Medical University of Vienna · ATHarokopio University of Athens · GRKarl Landsteiner Society · ATKlinik Hietzing · ATUniversity of Peloponnese · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRegular physical activities have a positive effect on the muscular skeletal system but overstrenuous exercise may be different. Transiently suppressed bone formation and increased bone resorption after participation in a 246-km ultradistance race has been demonstrated. PURPOSE: The aim of this study was to analyze effects of the Spartathlon race on novel musculoskeletal markers.

methodsVenous blood samples were obtained before and immediately after the race from 19 participants of the Spartathlon. From 9 runners who were available 3 days after the start blood was drawn for a third time. Serum levels of myostatin, an inhibitor of myogenic differentiation, and its opponent follistatin as well as sclerostin and dickkopf-1, both of them inhibitors of the wnt signaling pathway, and markers of bone turnover were determined.

resultsSerum levels of myostatin were significantly higher after the race. Serum follistatin only showed a transient increase. Sclerostin levels did not significantly differ before and after the race, whereas dickkopf-1 levels were significantly decreased. At follow-up a decrement of sclerostin and dickkopf-1 levels was seen. Serum cathepsin K levels did not change.

conclusionThe increase of serum levels of myostatin appears to reflect muscle catabolic processes induced by overstrenuous exercise. After the short-term uncoupling of bone turnover participation in an ultradistance race seems to initiate a long-term positive effect on bone indicated by the low-level inhibition of the Wnt/β-catenin signaling pathway.

Indexed as

Adaptor Proteins, Signal TransducingAdultBiomarkersBone Morphogenetic ProteinsBone ResorptionCathepsin KCollagen Type IFemaleFollistatinGenetic MarkersHumansIntercellular Signaling Peptides and ProteinsMaleMiddle AgedMuscle, SkeletalMyostatinAdaptor Proteins, Signal TransducingBiomarkersBone Morphogenetic ProteinsCathepsin KCollagen Type Icollagen type I trimeric cross-linked peptideCTSK protein, humanDKK1 protein, humanFollistatinFST protein, humanGenetic MarkersIntercellular Signaling Peptides and ProteinsMSTN protein, humanMyostatinPeptide FragmentsPeptidesProcollagenprocollagen Type I N-terminal peptideSOST protein, human

Identifiers

PMID26147574
PMCPMC4493015
OpenAlexW840668218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.